News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds
A company formed as a spinout from Cancer Research UK-funded science at The Institute of Cancer Research, London, has been publicly launched – revealing $32.5m in funding and a library of innovative anti-cancer compounds.
Isabella’s gift: The precious donation aiding vital research into childhood brain cancer
The parents of Isabella Ortiz, who died from a brain tumour, have highlighted the need for rare tissue donation, to help other children facing the same condition.
ICR statement regarding Black Lives Matter
As an organisation that believes passionately in equality, we want to express our solidarity with our Black, Asian and minority ethnic staff following the death of George Floyd.
Mini tumours help predict how cancer handles the heat of innovative cancer treatments
Scientists have shown that therapies which combine heat and radiation have a different effect on lab-grown mini tumours than they do on lab-grown cancer cells grown in a more traditional way in a two-dimensional layer.
Pioneer in building collaboration across research fields joins as Scientific Director of the Cancer Research UK Convergence Science Centre
The Institute of Cancer Research, London, and Imperial College London have appointed a leading expert in building interdisciplinary partnerships to head our joint Cancer Research UK Convergence Science Centre.
ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer
Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease, a new pilot study shows.
ASCO 2020: Blood test predicts response to prostate cancer treatment
A new blood test can predict how well men with advanced prostate cancer will respond to treatment and could replace some of the existing methods used to characterise and track the disease.
ASCO 2020: New optimised precision radiotherapy can reduce swallowing difficulties for head and neck cancer patients
A new optimised intensity-modulated radiation therapy (IMRT) could spare head and neck cancer patients’ adverse life-long side effects after treatment, new clinical trial results have shown.
-547x410.jpg?sfvrsn=c727183b_2 "Non-small cell lung cancer (photo Dr Ed Uthman-Yale Rosen-Flickr) 547x410")
AI could predict risk of lung cancer coming back
Computer scientists working with pathologists have trained an artificial intelligence (AI) tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment.
Prostate cancer gets first gene-targeted medicines
The Institute of Cancer Research, London, has strongly welcomed the approval by the US Food and Drug Administration (FDA) of the genetically targeted drug olaparib for some men with advanced prostate cancer.
Thousands of lives could be lost to delays in cancer surgery during COVID-19 pandemic
Delays to cancer surgery and other treatment caused by the coronavirus crisis could result in thousands of additional deaths linked to the pandemic in England, a major new study reports.
Mapping how evolutionary forces affect cancer growth could help doctors choose biopsies
A computer model that uses the principles of evolution to map the growth of populations of cancer cells in tumours could help doctors choose where to take biopsies from tumours, improving decisions about treatment.
